Oluwaseun Falade-Nwulia
Johns Hopkins University, MD·Public Health & Epidemiology·Early-career
People who use drugs face high risks of HIV, hepatitis C and overdose. Effective medicines exist, but many people never start or keep using them.
- Fields
Public Health & Epidemiology
Medicine & Clinical Research
Social Science
- Topics
hepatitis C
substance use disorder
opioid use disorder
- Grants
- 2 known grants, through Jul 2031
What they work on
- Adapt an existing social network intervention to rural settings with community input, so peer educators can distribute HIV self-testing kits and link people who use drugs to telemedicine care at community organizations.
- Test whether the peer-delivered HIV self-testing and navigation intervention increases HIV testing and uptake of PrEP or HIV treatment compared with a control condition, in a randomized trial.
- Characterize how the rural intervention is implemented using mixed methods, and measure how much HIV service uptake spreads through social influence within drug-use networks.
- Build behavioral economics strategies such as defaults, friction reduction, incentives and commitment devices into integrated HIV and substance use disorder care for people who use drugs.
- Evaluate these behavioral economics strategies with mixed-methods and cost-effectiveness analyses in community and rural Maryland settings, while mentoring early-stage investigators through the NICE Program.
More about the research
Barriers include low awareness, urgent needs like food and housing, and, in rural areas, few nearby services. Two projects study how to turn available treatments into actual use. They use implementation science, the study of how proven care gets adopted in real settings.
Why it matters
Rural people who use drugs often lack access to HIV prevention, HIV treatment and addiction care. Peer-delivered self-testing linked to telemedicine at trusted community organizations could raise testing and treatment uptake. Low-cost behavioral nudges tested for cost-effectiveness could give health systems and policymakers scalable ways to improve HIV, hepatitis C and opioid use disorder outcomes.
Known grants
From NIH and NSF research grants. Labs often have other funding we can't see.
Closest labs
Hansel Tookes
University of Miami, FL·Public Health & Epidemiology
Determine whether the Comprehensive-TeleHealth-concieRge model increases engagement in HIV prevention compared with offsite referral plus peer navigation, in a randomized trial of 350 people who inject drugs recruited at a low barrier clinic in Miami.
Susan Sherman
Johns Hopkins University, MD·Public Health & Epidemiology
Adapt Mobile SPARC outreach services for women who use drugs by identifying factors that help or hinder service use, through in-depth interviews with 40 women and 5 staff members.
Omeid Heidari
University of Washington, WA·Public Health & Epidemiology·Early-career
Design the Community-Based Opioid Treatment (CBOT) strategy and its implementation plan through interviews with patients, providers, nurses and other stakeholders, then pilot and refine it with 10 participants over three months.
The school
Johns Hopkins University: 100 labs on PI Pages, $4.1B a year on research, 622 research doctorates a year.
Reach out
A start for your email. Fill in the brackets.